154 related articles for article (PubMed ID: 1511462)
1. Cellular immunosuppression in children with acute lymphoblastic leukemia: effect of consolidation chemotherapy.
Komada Y; Zhang SL; Zhou YW; Hanada M; Shibata T; Azuma E; Sakurai M
Cancer Immunol Immunother; 1992; 35(4):271-6. PubMed ID: 1511462
[TBL] [Abstract][Full Text] [Related]
2. Time-course of the recovery of cellular immune function after high-dose chemotherapy and peripheral blood progenitor cell transplantation for high-grade non-Hodgkin's lymphoma.
Scheid C; Pettengell R; Ghielmini M; Radford JA; Morgenstern GR; Stern PL; Crowther D
Bone Marrow Transplant; 1995 Jun; 15(6):901-6. PubMed ID: 7581089
[TBL] [Abstract][Full Text] [Related]
3. TNF alpha enhancement of NK and LAK cell functions induced by high-dose IL-2 in human peripheral blood mononuclear cells from patients pretreated with alpha IFN + IL-2.
Favrot M; Combaret V; Blay JY; Capdeville R; Zhou DC; Clapisson G; Chouaib S; Franks CR; Philip T
Eur Cytokine Netw; 1990; 1(4):221-7. PubMed ID: 2104243
[TBL] [Abstract][Full Text] [Related]
4. [Immunologic monitoring in children with acute lymphoblastic leukemia during maintenance treatment with regard to co-existing infections].
Luczyński W; Stasiak-Barmuta A; Krawczuk-Rybak M; Zak J
Wiad Lek; 2004; 57(7-8):337-42. PubMed ID: 15631188
[TBL] [Abstract][Full Text] [Related]
5. A recycling defect as a characteristic of natural killer cells in childhood acute lymphoblastic leukemia.
Yabuhara A; Kawai H
Pediatr Res; 1990 Dec; 28(6):572-8. PubMed ID: 2284152
[TBL] [Abstract][Full Text] [Related]
6. Decreased interleukin-15 from activated cord versus adult peripheral blood mononuclear cells and the effect of interleukin-15 in upregulating antitumor immune activity and cytokine production in cord blood.
Qian JX; Lee SM; Suen Y; Knoppel E; van de Ven C; Cairo MS
Blood; 1997 Oct; 90(8):3106-17. PubMed ID: 9376592
[TBL] [Abstract][Full Text] [Related]
7. Defective natural killer cell activity and deficient production of interferon-gamma in children with acute lymphoblastic leukemia.
Wakiguchi H; Kubota H; Hisakawa H; Fujieda M; Kurashige T
Acta Paediatr Jpn; 1994 Aug; 36(4):361-5. PubMed ID: 7941997
[TBL] [Abstract][Full Text] [Related]
8. Immune reconstitution during maintenance therapy in children with acute lymphoblastic leukemia, relation to co-existing infection.
El-Chennawi FA; Al-Tonbary YA; Mossad YM; Ahmed MA
Hematology; 2008 Aug; 13(4):203-9. PubMed ID: 18796245
[TBL] [Abstract][Full Text] [Related]
9. Decrease in number of CD16(Leu 11)+CD45RA(2H4)+ cells and defective production of natural killer cytotoxic factor in childhood acute lymphoblastic leukemia.
Yamada S; Komiyama A
Leuk Res; 1991; 15(9):785-90. PubMed ID: 1833597
[TBL] [Abstract][Full Text] [Related]
10. Increased natural killer cell activity and numbers of Leu-7 and Leu-11b (CD 16)-positive cells in bone marrow of children in remission from acute lymphoblastic leukaemia.
Sørskaar D; Førre O; Lie SO
Scand J Immunol; 1989 Jan; 29(1):65-72. PubMed ID: 2466327
[TBL] [Abstract][Full Text] [Related]
11. Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukaemia: implications for successful treatment and possible therapeutic strategies.
Yamada O; Ichikawa M; Okamoto T; Park C; Motoji T; Mizoguchi H; Shibuya A
Br J Haematol; 2001 Apr; 113(1):153-60. PubMed ID: 11328295
[TBL] [Abstract][Full Text] [Related]
12. Cell-mediated cytotoxicity in children during and after therapy for acute lymphoblastic leukemia.
Aricò M; Lanfranchi A; Molinari E; Maccario R; Nespoli L; Burgio GR
Pediatr Hematol Oncol; 1988; 5(4):279-86. PubMed ID: 3152973
[TBL] [Abstract][Full Text] [Related]
13. Effects of first-line chemotherapy on natural killer cells in adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma.
Ogura M; Ishida T; Tsukasaki K; Takahashi T; Utsunomiya A
Cancer Chemother Pharmacol; 2016 Jul; 78(1):199-207. PubMed ID: 27289375
[TBL] [Abstract][Full Text] [Related]
14. The relationship between multi-drug resistance and resistance to natural-killer-cell and lymphokine-activated killer-cell lysis in human leukemic cell lines.
Treichel RS; Olken S
Int J Cancer; 1992 Jan; 50(2):305-10. PubMed ID: 1370437
[TBL] [Abstract][Full Text] [Related]
15. Isolation of human NK cells and generation of LAK activity.
Whiteside TL
Curr Protoc Immunol; 2001 May; Chapter 7():Unit 7.7. PubMed ID: 18432847
[TBL] [Abstract][Full Text] [Related]
16. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
[TBL] [Abstract][Full Text] [Related]
17. Impaired T and NK cell response of bone marrow and peripheral blood stem cell products to interleukin (IL)-2.
Ozerol I; Ageitos A; Heimann DG; Talmadge JE
Int J Immunopharmacol; 1999 Aug; 21(8):509-21. PubMed ID: 10458540
[TBL] [Abstract][Full Text] [Related]
18. The regulation and biological activity of interleukin 12.
Lee SM; Suen Y; Qian J; Knoppel E; Cairo MS
Leuk Lymphoma; 1998 May; 29(5-6):427-38. PubMed ID: 9643557
[TBL] [Abstract][Full Text] [Related]
19. Assay of lymphokine-activated killer activity generated from bone marrow cells of children with acute lymphoblastic leukemia.
Zhou MX; Findley HW; Davis R; Ragab AH
Blood; 1990 Jan; 75(1):160-5. PubMed ID: 2294987
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of NK cells in Mexican pediatric patients with acute lymphoblastic leukemia: Report from the Mexican Interinstitutional Group for the Identification of the Causes of Childhood Leukemia.
Valenzuela-Vazquez L; Núñez-Enríquez JC; Sánchez-Herrera J; Jiménez-Hernández E; Martín-Trejo JA; Espinoza-Hernández LE; Medina-Sanson A; Flores-Villegas LV; Peñaloza-González JG; Refugio Torres-Nava J; Espinosa-Elizondo RM; Amador-Sánchez R; Santillán-Juárez JD; Flores-Lujano J; Pérez-Saldívar ML; García-López LR; Castañeda-Echevarría A; Rodríguez-Leyva F; Rosas-Vargas H; Mata-Rocha M; Duarte-Rodríguez DA; Sepúlveda-Robles OA; Mancilla-Herrera I; Mejía-Aranguré JM; Cruz-Munoz ME
PLoS One; 2020; 15(1):e0227314. PubMed ID: 31951638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
